Belvedere Trading
GOSS icon

Belvedere Trading’s Gossamer Bio GOSS Stock Holding History

Belvedere Trading’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43,509
Closed -$523K – 1161
2022
Q3 		$523K Buy
43,509
+10,892
+33% +$135K 0.02% 73
2022
Q2 		$391K Buy
+32,617
New +$253K 0.01% 108
2022
Q1 		– Sell
-14,089
Closed -$145K – 524
2021
Q4 		$145K Buy
+14,089
New +$167K 0.01% 251

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Belvedere Trading's GOSS Position: Q4 2022 in Review

Belvedere Trading sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 43,509 shares — an estimated $523K sold.

Belvedere Trading first reported a position in GOSS in Q4 2021 and held it in 3 quarters. The position peaked at $523K in Q3 2022. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Belvedere Trading reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Belvedere Trading sold 43,509 Gossamer Bio shares in Q4 2022, an estimated $523K.
  • Belvedere Trading first reported a position in Gossamer Bio in Q4 2021 and held it in 3 quarters.
  • Belvedere Trading's Gossamer Bio position peaked at $523K in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Belvedere Trading's 13F filing for Q4 2022, filed 15 Feb 2023.